- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01502891
Making Decisions About Depression Medications (iADAPT)
30 décembre 2015 mis à jour par: Victor Montori
Translation of Comparative Effectiveness of Depression Medications Into Practice
The purpose of this study is to determine whether the Depression Medication Choice decision aid is effective in involving patients with depression in making deliberate choices when considering medication treatment.
Aperçu de l'étude
Description détaillée
To determine the ability of decision aids to effectively translate a depression comparative effectiveness research (CER) review into practice, the investigators have developed a literacy-sensitive depression treatment decision aid, DEPRESSION MEDICATION CHOICE, which adapts the Agency for Healthcare Research and Quality (AHRQ)'s Effective Healthcare comparative effectiveness review and associated patient guide about antidepressant medicines to satisfy the needs of clinicians, patients, and other major stakeholders.
The investigators will conduct a randomized study to estimate the effect of the decision aid on patient knowledge, patient involvement in decision making and decision-making quality, and on three and six-month measures of medication adherence and mental health, when compared with usual care.
Type d'étude
Interventionnel
Inscription (Réel)
301
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Minnesota
-
Minneapolis, Minnesota, États-Unis, 55415
- Hennepin County Medical Center
-
Rochester, Minnesota, États-Unis, 55905
- Mayo Clinic
-
St. Paul, Minnesota, États-Unis, 55117
- Entira Family Clinics (formerly known as Family Health Services Minnesota)
-
-
Wisconsin
-
LaCrosse, Wisconsin, États-Unis, 54601
- Mayo Clinic Health System - Franciscan Healthcare
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Presumed diagnosis of depression (PHQ-9 of 10 or greater)
- As judged by clinician, need to initiate drug treatment for depression
- Identify primary care clinician as main depression provider
- Agree to be available for follow-up survey 6 months after treatment decision
Exclusion Criteria:
- Has prior diagnosis of bipolar disorder
- Has major communication barrier (severe hearing/vision impairment, dementia, cannot communicate with clinician in same language)
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: Decision aid
DEPRESSION CHOICE decision aid is provided to clinician to share with patient
|
The decision aid, Depression Medication Choice, uses plain language and is designed to enhance patient understanding and satisfy the International Patient Decision Aid Standards (IPDAS) requirements for a safe and unbiased decision aid.
|
Aucune intervention: Soins normaux
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Quality of Decision Making
Délai: Immediately following each patient's index visit and before they leave the clinic on that day, typically within 10 minutes of completing the clinical encounter.
|
A modified Decisional Conflict Scale will be used to ascertain decisional quality and satisfaction with decision making.
The OPTION scale will be used to assess patient involvement in decision-making by reviewing video recordings of primary care visits with inter-rater reliability.
Satisfaction with decision making will be assessed also by using two specific questions that require patients to assess the extent to which they would want for themselves and recommend to others similar decision support like what they received during the visit.
|
Immediately following each patient's index visit and before they leave the clinic on that day, typically within 10 minutes of completing the clinical encounter.
|
Knowledge Transfer
Délai: Immediately following each patient's index visit and before they leave the clinic on that day, typically within 10 minutes of completing the clinical encounter.
|
Questions have been crafted to assess knowledge about depression treatment contained in the decision aid.
These questions use a response format "true/false/unsure," and are to be answered with full access to the decision aids since they are not a test of recall, but of 'use of information.'
|
Immediately following each patient's index visit and before they leave the clinic on that day, typically within 10 minutes of completing the clinical encounter.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
Reach and Fidelity of Use of Decision Aids
Délai: At end of study (approximately 2 years)
|
Reach will be estimated by the proportion of the eligible patients who received the intervention of the entire eligible population allocated to its use.
Fidelity will be determined using a checklist for each encounter to determine the proportion of visits in which more than >80% of decision aid items were delivered.
|
At end of study (approximately 2 years)
|
Medication Adherence to Antidepressants
Délai: Six months post-prescription
|
Investigators will obtain pharmacy records to determine anti-depressant use, adherence, and persistence based on prescription refills.
|
Six months post-prescription
|
Depression Control
Délai: At six months post index visit
|
Investigators will assess patients at baseline, 3 and 6 months using the Patient Health Questionnaire 9 (PHQ-9) to measure the extent to which their depressed symptoms changed over time.
|
At six months post index visit
|
Clinician Satisfaction with Decision Aids
Délai: Immediately following each patient's index visit and before they leave the clinic on that day, typically within 10 minutes of completing the clinical encounter.
|
Investigators will survey clinicians at the end of each index visit with a standardized clinician satisfaction questionnaire.
|
Immediately following each patient's index visit and before they leave the clinic on that day, typically within 10 minutes of completing the clinical encounter.
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Kunneman M, Branda ME, Ridgeway JL, Tiedje K, May CR, Linzer M, Inselman J, Buffington ALH, Coffey J, Boehm D, Deming J, Dick S, van Houten H, LeBlanc A, Liesinger J, Lima J, Nordeen J, Pencille L, Poplau S, Reed S, Vannelli A, Yost KJ, Ziegenfuss JY, Smith SA, Montori VM, Shah ND. Making sense of diabetes medication decisions: a mixed methods cluster randomized trial using a conversation aid intervention. Endocrine. 2022 Feb;75(2):377-391. doi: 10.1007/s12020-021-02861-4. Epub 2021 Sep 9. Erratum In: Endocrine. 2022 Nov 10;:
- LeBlanc A, Herrin J, Williams MD, Inselman JW, Branda ME, Shah ND, Heim EM, Dick SR, Linzer M, Boehm DH, Dall-Winther KM, Matthews MR, Yost KJ, Shepel KK, Montori VM. Shared Decision Making for Antidepressants in Primary Care: A Cluster Randomized Trial. JAMA Intern Med. 2015 Nov;175(11):1761-70. doi: 10.1001/jamainternmed.2015.5214.
- LeBlanc A, Bodde AE, Branda ME, Yost KJ, Herrin J, Williams MD, Shah ND, Houten HV, Ruud KL, Pencille LJ, Montori VM. Translating comparative effectiveness of depression medications into practice by comparing the depression medication choice decision aid to usual care: study protocol for a randomized controlled trial. Trials. 2013 May 7;14:127. doi: 10.1186/1745-6215-14-127.
Liens utiles
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 décembre 2011
Achèvement primaire (Réel)
1 octobre 2013
Achèvement de l'étude (Réel)
1 octobre 2013
Dates d'inscription aux études
Première soumission
23 décembre 2011
Première soumission répondant aux critères de contrôle qualité
30 décembre 2011
Première publication (Estimation)
2 janvier 2012
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
31 décembre 2015
Dernière mise à jour soumise répondant aux critères de contrôle qualité
30 décembre 2015
Dernière vérification
1 décembre 2015
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 11-003507
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Decision Aid
-
Chinese University of Hong KongRecrutementColoscopie de dépistageHong Kong
-
University of Alabama at BirminghamNational Cancer Institute (NCI)RecrutementCancer | Membres de la familleÉtats-Unis
-
University of Alabama at BirminghamComplétéCancer | Aidants familiauxÉtats-Unis
-
Chinese University of Hong KongComplété
-
Christina Murphey, RN, PhDSuspendu
-
Christina Murphey, RN, PhDRésiliéLa dépression | Insomnie | Anxiété | Qualité du sommeilÉtats-Unis
-
Fondazione Poliambulanza Istituto OspedalieroComplétéAdénome Côlon | Adénome coliqueItalie
-
Butler HospitalBrown University; University of Rhode IslandInscription sur invitation
-
University of LeicesterLOROS Hospice LeicesterRecrutement
-
The Mentholatum CompanyComplétéŒil sec | Syndromes de sécheresse oculaireÉtats-Unis